Xeno Acquisition Corp. /
ESSA Pharma Inc.
Xeno Acquisition Corp. to acquire ESSA Pharma Inc. in business combination
Source for the buyer and target: ESSA Pharma Inc.
For the buyer and target.
“On September 23, 2025, ESSA Pharma Inc., a company existing under the laws of the Province of British Columbia (the “ Company ”), entered into the Amendment Agreement (the “ Amendment ”) to the Business Combination Agreement (as amended by the Amendment, the “ Agreement ”), dated as of July 13, 2025, by and among the Company, XenoTherapeutics, Inc., a Massachusetts non-profit corporation (“ Xeno ”), Xeno Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Xeno and solely for purposes of Section 10.16 thereof, XOMA Royalty Corporation, a Nevada corporation (“ XRC ”).”
Published 24 Sep 2025
Open the sourceWhat happened
Xeno Acquisition Corp. agreed to acquire all of the issued and outstanding common shares of ESSA Pharma Inc. under a statutory plan of arrangement. The companies amended their Business Combination Agreement on Sept. 23, 2025. [01]
Terms weren't disclosed. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Xeno Acquisition Corp. to acquire ESSA Pharma Inc. in business combination
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
“The companies amended their Business Combination Agreement on Sept. 23, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly